Resources
Search >>
Search >>
Have questions about the Eurofins’ Infant Formula Contaminant Certification or Eurofins Protocol 102? Check out our guide for the answers to frequently asked questions regarding this type of certification.
Keywords:
Blog
Infant Formula
The United States Pharmacopeia (USP) is rolling out important updates to General Chapters <2021> and <2022> and, taking effect on April 1, 2026. For manufacturers who rely on microbiological testing to ensure product quality and regulatory compliance, understanding what’s changing and what actions are required is essential.
Important upcoming updates to USP Chapters <2021> and <2022 went into effect on April 1, 2026. These changes modify several microbiological testing requirements, including incubation times, suitability testing, and enrichment steps for specific organisms. Check out our answers to frequently asked questions about the updates.


